These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23696149)

  • 1. Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts.
    Berasain C; Avila MA
    Hepatology; 2013 Sep; 58(3):853-5. PubMed ID: 23696149
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
    Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma: current concepts and insights.
    Gores GJ
    Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation.
    DeMorrow S
    Dig Liver Dis; 2009 Feb; 41(2):164-5. PubMed ID: 19112054
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrahepatic cholangiocarcinoma arising in autosomal dominant polycystic kidney disease.
    Sasaki M; Katayanagi K; Watanabe K; Takasawa K; Nakanuma Y
    Virchows Arch; 2002 Jul; 441(1):98-100. PubMed ID: 12192647
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholangiocellular carcinoma (intrahepatic bile duct carcinoma)].
    Tarao K; Tamai S; Ohkawa S; Miyakawa K; Aoki H
    Ryoikibetsu Shokogun Shirizu; 1995; (7):476-9. PubMed ID: 8749530
    [No Abstract]   [Full Text] [Related]  

  • 7. The activation of platelet aggregation by human cholangiocarcinoma cells is mediated through thrombin receptor.
    Akarasereenont P; Chotewuttakorn S; Aiamsa-Ard T; Thaworn A
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S710-21. PubMed ID: 12002913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrahepatic bile duct adenocarcinoma].
    Terada T; Nakanuma Y
    Ryoikibetsu Shokogun Shirizu; 1995; (7):402-4. PubMed ID: 8749507
    [No Abstract]   [Full Text] [Related]  

  • 9. JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?
    Smirnova OV; Ostroukhova TY; Bogorad RL
    World J Gastroenterol; 2007 Dec; 13(48):6478-91. PubMed ID: 18161917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
    Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular pathogenesis of cholangiocarcinoma.
    Berthiaume EP; Wands J
    Semin Liver Dis; 2004 May; 24(2):127-37. PubMed ID: 15192786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma.
    Taguchi K; Aishima S; Asayama Y; Kajiyama K; Kinukawa N; Shimada M; Sugimachi K; Tsuneyoshi M
    Hepatology; 2001 May; 33(5):1118-23. PubMed ID: 11343239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
    Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
    Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
    Gentilini A; Pastore M; Marra F; Raggi C
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma.
    Wu T
    Biochim Biophys Acta; 2005 Jul; 1755(2):135-50. PubMed ID: 15921858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
    Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.
    Sirica AE; Nathanson MH; Gores GJ; Larusso NF
    Hepatology; 2008 Dec; 48(6):2040-6. PubMed ID: 18855901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.